Literature DB >> 29323607

Efficacy of oral vancomycin in primary prevention of Clostridium Difficile infection in elderly patients treated with systemic antibiotic therapy.

Neven Papic1, Lorna Stemberger Maric1,2, Adriana Vince1,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29323607     DOI: 10.1080/23744235.2018.1425551

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


× No keyword cloud information.
  5 in total

Review 1.  Does oral vancomycin use necessitate therapeutic drug monitoring?

Authors:  Nevio Cimolai
Journal:  Infection       Date:  2019-11-11       Impact factor: 3.553

Review 2.  Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis.

Authors:  Alberto Enrico Maraolo; Maria Mazzitelli; Emanuela Zappulo; Riccardo Scotto; Guido Granata; Roberto Andini; Emanuele Durante-Mangoni; Nicola Petrosillo; Ivan Gentile
Journal:  Antibiotics (Basel)       Date:  2022-01-30

3.  Nonalcoholic fatty liver disease as a risk factor for Clostridioides difficile infection.

Authors:  Neven Papić; Fabijan Jelovčić; Marko Karlović; Lorna Stemberger Marić; Adriana Vince
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-11-28       Impact factor: 3.267

4.  Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis.

Authors:  Raseen Tariq; Maryrose Laguio-Vila; Muhammad Waqas Tahir; Robert Orenstein; Darrell S Pardi; Sahil Khanna
Journal:  Therap Adv Gastroenterol       Date:  2021-02-23       Impact factor: 4.409

5.  Nonalcoholic Fatty Liver Disease-A Novel Risk Factor for Recurrent Clostridioides difficile Infection.

Authors:  Lara Šamadan; Mia Jeličić; Adriana Vince; Neven Papić
Journal:  Antibiotics (Basel)       Date:  2021-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.